MK-1942, A NEGATIVE ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTOR 2, FOR TREATMENTRESISTANT DEPRESSION

被引：0

作者：

Merola, Aristide ^{[1
]}

Mukai, Yuki ^{[1
]}

Bueters, Tjerk ^{[1
]}

Ceesay, Paulette ^{[1
]}

Dupre, Nicole ^{[1
]}

Furtek, Christine ^{[1
]}

Sanacora, Gerard ^{[1
]}

Thase, Michael ^{[1
]}

Targum, Steven D. ^{[1
]}

Alexopoulou, Zoi ^{[1
]}

Mahon, Chantal ^{[1
]}

Li, Wenping ^{[1
]}

Miller, Callie ^{[1
]}

Yee, Kelly ^{[1
]}

Smith, Sean M. ^{[1
]}

Uslaner, Jason ^{[1
]}

Stoch, Aubrey ^{[1
]}

Egan, Michael ^{[1
]}

机构：

[1] Merck & Co Inc, Rahway, NJ 07065 USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2024年 / 49卷

关键词：

Treatment Resistant Depression; Metabotropic glutamate receptor 2 (mGluR2); randomized clinical trial;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

P648

引用

页码：440 / 441

页数：2

共 50 条

[41] Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Kampen, Stefanie
Rodriguez, David
Jorgensen, Morten
Kruszyk-Kujawa, Monika
Huang, Xinyan
Collins, Michael, Jr.
Boyle, Noel
Maurel, Damien
Rudling, Axel
Lebon, Guillaume
Carlsson, Jens
ACS CHEMICAL BIOLOGY, 2022, 17 (10) : 2744 - 2752
[42] Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators
Shah, Falgun
Stepan, Antonia F.
O'Mahony, Alison
Velichko, Sharlene
Folias, Alexandra E.
Houle, Christopher
Shaffer, Christopher L.
Marcek, John
Whritenour, Jessica
Stanton, Robert
Berg, Ellen L.
CELL CHEMICAL BIOLOGY, 2017, 24 (07): : 858 - +
[43] Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia
Fraley, Mark E.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1259 - 1275
[44] Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
Trabanco, A. A.
Cid, J. M.
Lavreysen, H.
Macdonald, G. J.
Tresadern, G.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (01) : 47 - 68
[45] Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM)
Piotr Brański
Jakub Staroń
Ryszard Bugno
Joanna Wierońska
Andrzej Bojarski
Grzegorz Burnat
Agnieszka Pałucha-Poniewiera
Andrzej Pilc
Pharmacological Reports, 2011, 63 (2) : 577 - 577
[46] Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM)
Branski, Piotr
Staron, Jakub
Bugno, Ryszard
Wieronska, Joanna
Bojarski, Andrzej
Burnat, Grzegorz
Palucha-Poniewiera, Agnieszka
Pilc, Andrzej
PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 577 - 577
[47] Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
Hikichi, Hirohiko
Hiyoshi, Tetsuaki
Marumo, Toshiyuki
Tomishima, Yasumitsu
Kaku, Ayaka
Iida, Izumi
Urabe, Hiroki
Tamita, Tomoko
Yasuhara, Akito
Karasawa, Jun-ichi
Chaki, Shigeyuki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (03) : 352 - 361
[48] Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation
Gregory, Karen J.
Conn, P. Jeffrey
MOLECULAR PHARMACOLOGY, 2015, 88 (01) : 188 - 202
[49] In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5
Zysk, John R.
Spear, Nathan
Fieles, William
Stein, Mark M.
Sygowski, Linda S.
King, Megan M.
Hoesch, Valerie
Hastings, Richard
Brockel, Becky
Do, Mylinh
Strom, Peter
Gadient, Reto
Chhajlani, Vijay
Elmore, Charles S.
Maier, Donna L.
SYNAPSE, 2013, 67 (03) : 135 - 144
[50] In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article
R. Kuhn
A. Pagano
N. Stoehr
I. Vranesic
P. J. Flor
K. Lingenhöhl
W. Spooren
C. Gentsch
A. Vassout
A. Pilc
F. Gasparini
Amino Acids, 2002, 23 : 207 - 211

← 1 2 3 4 5 →